Cantel Medical Corp. Announces New President and CEO.LITTLE FALLS, N.J. -- CANTEL MEDICAL CORP. (NYSE NYSE See: New York Stock Exchange :CMN CMN Common CMN Children's Miracle Network (since 1983; Salt Lake City, Utah) CMN Certificate of Medical Necessity CMN Canadian Museum of Nature CMN Community Mapping Network CMN Common Information ) today announced the appointment of R. Scott Jones as President and Chief Executive Officer of the Company. Mr. Jones, who was selected following an extensive national search, is a veteran of the healthcare products and services industry. He most recently served as President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Symphony Health Services, Inc., a leading provider of contract healthcare services with over 6,000 employees. Symphony Health Services was acquired by RehabCare Group Inc. (NYSE: RHB) in July 2006. Prior to joining Symphony, Mr. Jones served as President and CEO of Accentia, Inc., an international specialty bio-pharmaceutical company, and as Chief Operating Officer Chief Operating Officer (COO) The officer of a firm responsible for day-to-day management, usually the president or an executive vice-president. at PharMerica, Inc., a provider of pharmacy products and services for specialized patient populations in long-term care and alternate care facilities, which was acquired by AmerisourceBergen Corporation (formerly Bergen Brunswick Corp.). Mr. Jones' background also includes extensive experience with global medical product companies, including an eight-year tenure with General Electric Medical Systems, where he led the X-Ray Products group for North and South America and held an international assignment in Tokyo, Japan. He currently serves as a Director for American Radiology Services, an affiliate of the Johns Hopkins University School of Medicine The Johns Hopkins University School of Medicine, located in Baltimore, Maryland, USA, is a highly regarded medical school and biomedical research institute in the United States. . Mr. Jones holds a Masters Degree in bioengineering from Pennsylvania State University Pennsylvania State University, main campus at University Park, State College; land-grant and state supported; coeducational; chartered 1855, opened 1859 as Farmers' High School. and a Bachelors degree in biochemistry and biophysics biophysics, application of various methods and principles of physical science to the study of biological problems. In physiological biophysics physical mechanisms have been used to explain such biological processes as the transmission of nerve impulses, the muscle from the State University of New York (body) State University of New York - (SUNY) The public university system of New York State, USA, with campuses throughout the state. . "The Cantel Board conducted a comprehensive search for the strongest candidate to lead the next stage of our growth," said Charles Diker dike 1 also dyke n. 1. a. An embankment of earth and rock built to prevent floods. b. Chiefly British A low wall, often of sod, dividing or enclosing lands. 2. , Chairman of the Board. "We are thrilled to bring Scott on board and believe his healthcare and acquisition experience will be a tremendous asset to the Company. With the successful integration of our Crosstex acquisition, the continuing development of Mar Cor Purification, and Minntech's leadership position in dialysis and endoscope reprocessing Reprocessing may refer to:
Mr. Jones stated, "I'm very pleased to join the Cantel team. The Company is well poised in the infection prevention and control marketplace for profitable growth via new product introductions, acquisitions and an expanded international presence. Given the importance of infection control in providing quality, cost-effective healthcare, Cantel's range of solutions and technologies addresses an area with growing focus and demand." Mr. Jones succeeds James P. Reilly, who is retiring after serving as President and CEO since 1989. "Jim has led Cantel for over 17 years, during which time we have grown and developed from a company with modest revenues and no proprietary products, to a leading manufacturer and provider of infection prevention and control products with over $200 million in sales," said Mr. Diker. "Jim has made major contributions to our growth and success and I want to thank him on behalf of our Board, stockholders and employees for his dedicated years of service." Cantel Medical Corp. is a leading provider of infection prevention and control products in the healthcare market. Our products include specialized medical device reprocessing systems for renal dialysis and endoscopy, dialysate dialysate /di·al·y·sate/ (di-al´i-sat) the fluid and solutes in a dialysis process that flow through the dialyzer, do not pass through the membrane, and are discarded along with removed toxic substances after leaving the dialyzer. concentrates and other dialysis supplies, disposable infection control products primarily for the dental industry, water purification equipment, sterilants, disinfectants and cleaners, hollow fiber membrane filtration and separation products for medical and non-medical applications, and specialty packaging for infectious and biological specimens. We also provide technical maintenance for our products and offer compliance training services for the transport of infectious and biological specimens. This press release contains forward-looking statements. All forward-looking statements involve risks and uncertainties, including, without limitation, the risks detailed in the Company's filings and reports with the Securities and Exchange Commission. Such statements are only predictions, and actual events or results may differ materially from those projected. For further information, visit the Cantel website at www.cantelmedical.com. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion